GOLD in practice: chronic obstructive pulmonary disease treatment and management in the primary care setting
BP Yawn, ML Mintz, DE Doherty - International journal of chronic …, 2021 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and
mortality. Early detection and appropriate treatment and management of COPD can lower …
mortality. Early detection and appropriate treatment and management of COPD can lower …
Sing Your Lungs Out—a community singing group for chronic obstructive pulmonary disease: a 1-year pilot study
A McNaughton, M Weatherall, M Williams… - BMJ open, 2017 - bmjopen.bmj.com
Objective Singing group participation may benefit patients with chronic obstructive
pulmonary disease (COPD). Previous studies are limited by small numbers of participants …
pulmonary disease (COPD). Previous studies are limited by small numbers of participants …
DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough
A Pelleg, F Xu, J Zhuang, B Undem… - … in respiratory disease, 2019 - journals.sagepub.com
Background: Extracellular adenosine 5′-triphosphate (ATP) plays important mechanistic
roles in pulmonary disorders in general and chronic obstructive pulmonary disease (COPD) …
roles in pulmonary disorders in general and chronic obstructive pulmonary disease (COPD) …
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
JA Wedzicha, N Zhong, M Ichinose… - … journal of chronic …, 2017 - Taylor & Francis
Background The FLAME study demonstrated that indacaterol/glycopyrronium (IND/GLY), the
fixed-dose combination of a long-acting β2-agonist (LABA, IND) and a long-acting …
fixed-dose combination of a long-acting β2-agonist (LABA, IND) and a long-acting …
Insights into glucocorticoid responses derived from omics studies
Glucocorticoid drugs are commonly used in the treatment of several conditions, including
autoimmune diseases, asthma and cancer. Despite their widespread use and knowledge of …
autoimmune diseases, asthma and cancer. Despite their widespread use and knowledge of …
Inhaled corticosteroid use and the incidence of lung cancer in COPD
S Suissa, S Dell'Aniello, AV Gonzalez… - European Respiratory …, 2020 - Eur Respiratory Soc
Background Inhaled corticosteroids (ICS) are suggested for potential chemoprevention of
lung cancer. Several observational studies in patients with chronic obstructive pulmonary …
lung cancer. Several observational studies in patients with chronic obstructive pulmonary …
SUL-151 decreases airway neutrophilia as a prophylactic and therapeutic treatment in mice after cigarette smoke exposure
L Wang, CE Pelgrim, DH Swart, G Krenning… - International journal of …, 2021 - mdpi.com
Chronic obstructive pulmonary disease (COPD) caused by cigarette smoke (CS) is featured
by oxidative stress and chronic inflammation. Due to the poor efficacy of standard …
by oxidative stress and chronic inflammation. Due to the poor efficacy of standard …
Microencapsulation of fluticasone propionate and salmeterol xinafoate in modified chitosan microparticles for release optimization
Chitosan (CS) is a natural polysaccharide, widely studied in the past due to its unique
properties such as biocompatibility, biodegradability and non-toxicity. Chemical modification …
properties such as biocompatibility, biodegradability and non-toxicity. Chemical modification …
A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
A D'Urzo, JF Donohue, P Kardos… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Inhaled corticosteroids (ICS)(in fixed combinations with long-acting β2-agonists
[LABAs]) are frequently prescribed for patients with chronic obstructive pulmonary disease …
[LABAs]) are frequently prescribed for patients with chronic obstructive pulmonary disease …
Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery
P Sharma, DS Dhanjal, C Chopra… - Chemico-Biological …, 2022 - Elsevier
Abstract Asthma, COPD, COVID-19, EGPA, Lung cancer, and Pneumonia are major chronic
respiratory diseases (or CRDs) affecting millions worldwide and account for substantial …
respiratory diseases (or CRDs) affecting millions worldwide and account for substantial …